bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · IEX Real-Time Price · USD
-0.130 (-9.63%)
At close: Jul 17, 2024, 4:00 PM
-0.010 (-0.82%)
After-hours: Jul 17, 2024, 7:01 PM EDT

bluebird bio Revenue

bluebird bio had revenue of $21.73M in the twelve months ending September 30, 2023, with 322.60% growth year-over-year. Revenue in the quarter ending September 30, 2023 was $12.39M with 17,353.52% year-over-year growth. In the year 2022, bluebird bio had annual revenue of $3.60M.

Revenue (ttm)
Revenue Growth
P/S Ratio
Revenue / Employee
Market Cap
235.15M USD

Revenue Chart


Fiscal Year End Revenue Change Growth
Dec 31, 20223.60M-65.00K-1.77%
Dec 31, 20213.66M--
Dec 31, 20200--
Dec 31, 20190--
Dec 31, 201854.58M19.15M54.06%
Dec 31, 201735.43M29.27M475.58%
Dec 31, 20166.16M-7.92M-56.28%
Dec 31, 201514.08M-11.34M-44.62%
Dec 31, 201425.42M5.24M25.97%
Dec 31, 201320.18M19.84M5,835.59%
Dec 31, 2012340.00K-542.00K-61.45%
Dec 31, 2011882.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MultiPlan 959.44M
Butterfly Network 68.08M
Sanara MedTech 68.00M
Aquestive Therapeutics 51.50M
AVITA Medical 51.50M
Mersana Therapeutics 38.30M
Revenue Rankings